U.S. Biofilms Treatment Market – Industry Trends and Forecast to 2030

U.S. Biofilms Treatment Market, By Wound Type (Traumatic and Surgical Wound, Diabetic Foot Ulcers, Open Wound, Pressure Ulcers, Venous Leg Ulcer, Chronic Sinusitis, Burns, Dental Plaque, Others), Methods (Prevention, Killing, Debridement), Site of Infection (Lung Infection, Rhinosinusitis, Wounds, Endotracheal Tubes, Catheters, Orthopedic Procedures), Product (Gauzes and Dressings, Wipes, Pads and Lavage Solutions, Gels, Ointment and Spray, Grafts and Matrices, Debridement Equipment, Others), Treatment (Biofilm Disruptors, Antimicrobial Treatments, Antibiotic Medication, Photo Inactivation, Others), Route of Administration (Topical, Oral, Others), End User (Hospitals, Wound Care Centers, Clinics, Home Healthcare, Ambulatory Surgical Centers, Others), Distribution Channel (Direct Tender, Pharmacies, Retail Sales, Others) – Industry Trends and Forecast to 2030.

U.S. Biofilms Treatment Market Analysis and Size

The growing number of wounds and hospital-acquired infections in the healthcare industry has increased the demand for biofilm treatment. Biofilm treatment is required to prevent contamination because implanted devices such as catheters and pacemakers are the primary sites for biofilm growth. According to the survey, biofilms are present in 60% to 70% of chronic wounds. This factor is expected to accelerate market growth.

Data Bridge Market Research analyses that the biofilms treatment market which is USD 4.70 billion in 2022, is expected to reach USD 8.20 billion by 2030, at a CAGR of 7.2% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

U.S. Biofilms Treatment Market Scope and Segmentation  

Market Definition

A "biofilm" is a group of microorganisms that live on various surfaces. The microorganisms that cause a biofilm to form are bacteria, protists, and fungi. Biofilms can be seen on animal tissues, pacemakers, implanted medical equipment such as catheters, and plant tissues. Biofilms can form on the earth's surface, in groundwater, on minerals, or on metals.

U.S. Biofilms Treatment Market Dynamics

Drivers

• Rise in Traumatic cases

The market is expanding due to an increase in traumatic injuries such as burns and car accidents. According to the WHO, approximately 1,000,000 Indians suffer from severe to moderate burn injuries each year in 2019. This factor is expected to boost market growth. Furthermore, according to the National Center for Biotechnology Information (NCBI), the countries with the highest incidences of burn injuries in 2018 were the United Kingdom, the Netherlands, Bulgaria, China, India, Australia, and Finland. According to a 2017 American Association for the Surgery of Trauma survey, approximately 1.2 million people die every day, with road accidents accounting for 3,342 deaths. These are some of the factors are likely to have an impact on market growth.

• Growing number of wounds and hospital-acquired infections

The growing number of wounds and hospital-acquired infections has increased the demand for biofilm in the healthcare industry. Biofilm treatment is required to prevent contamination because implanted devices such as catheters and pacemakers are primary sites for biofilm growth. According to the survey, biofilms are present in approximately 60% to 70% of chronic wounds. This factor is expected to hasten market growth.

• Rising demand for biofilm treatment

The growing prevalence of wounds, infections, and biofilms on medical devices is driving up demand for biofilm treatment. This factor is expected to boost the biofilm treatment market. Furthermore, the increasing prevalence of biofilms is expected to drive market growth during the forecast period. According to some studies, biofilms can be found on 60% to 100% of chronic wound samples. This factor defines biofilms' faster and spatial distribution in chronic wounds, driving the need for biofilm treatment.

Opportunities

• Government rules

Government-imposed standards and restrictions aimed at preventing contamination in healthy people are likely to spur market growth. For instance, the European society imposed strict guidelines and criteria for clinical microbiology and infectious disease detection and treatment to detect and treat infectious diseases caused by biofilm. This factor may increase demand for biofilm removal during the forecast period.

Restraints/Challenges

• High cost of treatment

The rising treatment costs and low penetration rate of wound care products will slow market growth. The market will be challenged by a lack of skilled professionals and a lack of healthcare infrastructure in developing economies.

This biofilms treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the biofilms treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

• In 2020, ConvaTec announced the release of ConvaMax, that aids in the management of highly draining wounds such as leg ulcers, surgical wounds, and diabetic foot ulcers.
• In 2020, Next Science Limited signed a partnership agreement with 3M for the exclusive distribution of BlastX, a gel used to treat biofilms formed over wounds. This distribution agreement assisted the company in increasing revenue by improving its distribution capabilities.

U.S. Biofilms Treatment Market Scope

The biofilms treatment market is segmented on the basis of wound type, site of infection, methods, product, treatment, route of administration, end user, and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Wound Type

• Traumatic
• Surgical Wound
• Diabetic Foot Ulcers
• Open Wound
• Pressure Ulcers
• Venous Leg Ulcer
• Chronic Sinusitis
• Burns
• Dental Plaque
• Others

 Methods

• Prevention
• Killing
• Debridement

Product

• Gauzes and Dressings
• Wipes
• Pads
• Lavage Solutions
• Gels
• Ointment
• Spray
• Grafts
• Matrices
• Debridement Equipment
• Others

 Treatment

• Biofilm Disruptors
• Antimicrobial Treatments
• Antibiotic Medication
• Photo Inactivation
• Others

Route of Administration

• Topical
• Oral
• Others

End User

• Hospitals
• Wound Care Centers
• Clinics
• Home Healthcare
• Ambulatory Surgical Centers
• Others

Distribution Channel

• Direct Tender
• Pharmacies
• Retail Sales
• Others

 Site of Infection

• Lung Infection
• Rhinosinusitis
• Wounds
• Surgical Wounds
• Diabetic Foot Ulcers
• Pressure Ulcers
• Burns
• Others
• Endotracheal Tubes
• Catheters
• Orthopedic Procedures

Competitive Landscape and Biofilms Treatment Market Share Analysis

The biofilms treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to biofilms treatment market.

Some of the major players operating in the biofilms treatment market are:

• Smith+Nephew (U.K.)
• MiMedx (U.S.)
• ConvaTec Group plc (U.K.)
• Coloplast Group (Denmark)
• Mölnlycke Healthcare AB (Sweden)
• Organogenesis Inc. (U.S.)
• Integra LifeSciences (U.S.)
• B. Braun SE (Germany)
• PAUL HARTMANN AG (Germany)
• Medline Industries Inc. (U.K.)
• Acelity (U.S.)
• Misonix (U.S.)
• Zimmer Biomet (U.S.)
• Kerecis (Iceland)
• Welcare Industries S.p.A (Italy)